Skip to content

Drug interactions

Buprenorphine subdermal implant + Sorafenib

Severity: Minor

Buprenorphine subdermal implant and Sorafenib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents have QT-prolonging potential, though the implant gives low, steady buprenorphine exposure. Added arrhythmia risk is small but possible in susceptible patients.

What this interaction means in plain words

Buprenorphine subdermal implant and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible additive QT prolongation.

What to do

Monitor ECG in patients with additional QT risk factors and keep electrolytes normal.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Sorafenib?

MediHelp rates the interaction as minor. Buprenorphine subdermal implant and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Both agents have QT-prolonging potential, though the implant gives low, steady buprenorphine exposure. Added arrhythmia risk is small but possible in susceptible patients.

How serious is the interaction between Buprenorphine subdermal implant and Sorafenib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG in patients with additional QT risk factors and keep electrolytes normal.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in